Irish Examiner1d
Acquisition activity in Irish sciences sector shifts to smaller deals
Some 17 companies successfully raised growth capital totalling €503m. This equates to a 254% increase in value terms compared ...
U.S. investors, Big Pharma race to find new medicines in China
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
Novo Nordisk: Dips Like These Come Once Every Few Years
Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...
Lilly Beats Benefit Interference Claim Over Credit Card Firing
A Lilly USA LLC employee fired for allegedly misusing a corporate credit card failed to mount a viable claim that he was ...
BioSpace3d
New M&A Action, BMS’ Ongoing Cost Cuts and the Insatiable Demand for Weight Loss Drugs
Novartis, Eli Lilly and more put on their deal-making caps, Bristol Myers Squibb targets $2 billion in savings through 2027, ...
Jim Cramer Backs Eli Lilly (LLY): Will Its Drug Pipeline Dominate Pharma?
We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...